Skip to Main content Skip to Navigation
Journal articles

Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy

Abstract : The European Association of Urology renal cancer guidelines have been updated to recommend nivolumab and cabozantinib over the previous standard of care in patients who have failed one or more lines of VEGF targeted therapy.
Complete list of metadata

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01220642
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Monday, October 26, 2015 - 4:35:33 PM
Last modification on : Wednesday, September 14, 2022 - 10:20:04 AM

Identifiers

Citation

Thomas Powles, Michael Staehler, Börje Ljungberg, Karim Bensalah, Steven E. Canfield, et al.. Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. European Urology, Elsevier, 2016, 69 (1), pp.4-6. ⟨10.1016/j.eururo.2015.10.017⟩. ⟨hal-01220642⟩

Share

Metrics

Record views

53